{"id":"https://openalex.org/W7166556707","doi":"https://doi.org/10.3389/fimmu.2026.1873839","title":"Antibiotic exposure and indication-specific corticosteroid use differentially modulate outcomes of immune checkpoint inhibitor therapy in hepatobiliary malignancies","display_name":"Antibiotic exposure and indication-specific corticosteroid use differentially modulate outcomes of immune checkpoint inhibitor therapy in hepatobiliary malignancies","alternate_titles":[],"publication_year":2026,"publication_date":"2026-06-29","ids":{"openalex":"https://openalex.org/W7166556707","doi":"https://doi.org/10.3389/fimmu.2026.1873839","pmid":"https://pubmed.ncbi.nlm.nih.gov/42445194","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13357655"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2026.1873839","doi":"https://doi.org/10.3389/fimmu.2026.1873839","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1873839","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1873839/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W7166556707"],"child_works_count":3,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1873839/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003527971","display_name":"Jiabao Yang","orcid":"https://orcid.org/0009-0005-1917-5809","observed_orcids":["https://orcid.org/0009-0005-1917-5809","https://orcid.org/0009-0007-3934-0685"]},"institutions":[{"id":"https://openalex.org/I4210121771","display_name":"First Affiliated Hospital of Xi'an Jiaotong University","ror":"https://ror.org/02tbvhh96","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210121771"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jiabao Yang","raw_affiliation_strings":["Department of Radiotherapy, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiotherapy, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China","institution_ids":["https://openalex.org/I4210121771"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5139598355","display_name":"Wenjuan Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121771","display_name":"First Affiliated Hospital of Xi'an Jiaotong University","ror":"https://ror.org/02tbvhh96","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210121771"]},{"id":"https://openalex.org/I87445476","display_name":"Xi'an Jiaotong University","ror":"https://ror.org/017zhmm22","country_code":"CN","type":"education","lineage":["https://openalex.org/I87445476"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wenjuan Wang","raw_affiliation_strings":["Department of Medical Oncology, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China","institution_ids":["https://openalex.org/I4210121771","https://openalex.org/I87445476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5121248343","display_name":"Min Jiao","orcid":"https://orcid.org/0000-0003-4502-5263","observed_orcids":["https://orcid.org/0000-0003-4502-5263"]},"institutions":[{"id":"https://openalex.org/I4210121771","display_name":"First Affiliated Hospital of Xi'an Jiaotong University","ror":"https://ror.org/02tbvhh96","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210121771"]},{"id":"https://openalex.org/I87445476","display_name":"Xi'an Jiaotong University","ror":"https://ror.org/017zhmm22","country_code":"CN","type":"education","lineage":["https://openalex.org/I87445476"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Min Jiao","raw_affiliation_strings":["Department of Medical Oncology, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China","institution_ids":["https://openalex.org/I4210121771","https://openalex.org/I87445476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008871716","display_name":"Z Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121771","display_name":"First Affiliated Hospital of Xi'an Jiaotong University","ror":"https://ror.org/02tbvhh96","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210121771"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zhekang Zhang","raw_affiliation_strings":["Department of Radiotherapy, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiotherapy, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China","institution_ids":["https://openalex.org/I4210121771"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087063292","display_name":"Shuwei Lei","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121771","display_name":"First Affiliated Hospital of Xi'an Jiaotong University","ror":"https://ror.org/02tbvhh96","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210121771"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shuwei Lei","raw_affiliation_strings":["Department of Radiotherapy, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiotherapy, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China","institution_ids":["https://openalex.org/I4210121771"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5117459261","display_name":"Ning Lan","orcid":"https://orcid.org/0000-0002-8447-9789","observed_orcids":["https://orcid.org/0000-0002-8447-9789"]},"institutions":[{"id":"https://openalex.org/I4210121771","display_name":"First Affiliated Hospital of Xi'an Jiaotong University","ror":"https://ror.org/02tbvhh96","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210121771"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ning Lan","raw_affiliation_strings":["Department of Radiotherapy, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiotherapy, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China","institution_ids":["https://openalex.org/I4210121771"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015566837","display_name":"M Y Chen","orcid":"https://orcid.org/0000-0002-6662-9587","observed_orcids":["https://orcid.org/0000-0002-6662-9587","https://orcid.org/0009-0001-8076-4785"]},"institutions":[{"id":"https://openalex.org/I4210121771","display_name":"First Affiliated Hospital of Xi'an Jiaotong University","ror":"https://ror.org/02tbvhh96","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210121771"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Min Chen","raw_affiliation_strings":["Department of Radiotherapy, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiotherapy, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China","institution_ids":["https://openalex.org/I4210121771"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5156217352","display_name":"Zirui Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I87445476","display_name":"Xi'an Jiaotong University","ror":"https://ror.org/017zhmm22","country_code":"CN","type":"education","lineage":["https://openalex.org/I87445476"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zirui Wang","raw_affiliation_strings":["Department of Medicine, Xi\u2032an Jiaotong University, Xi\u2032an, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Xi\u2032an Jiaotong University, Xi\u2032an, China","institution_ids":["https://openalex.org/I87445476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108739834","display_name":"Beina Hui","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121771","display_name":"First Affiliated Hospital of Xi'an Jiaotong University","ror":"https://ror.org/02tbvhh96","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210121771"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Beina Hui","raw_affiliation_strings":["Department of Radiotherapy, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiotherapy, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China","institution_ids":["https://openalex.org/I4210121771"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5139553976","display_name":"Tasneem Ibrahim Dawalbait Bakhat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121771","display_name":"First Affiliated Hospital of Xi'an Jiaotong University","ror":"https://ror.org/02tbvhh96","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210121771"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Tasneem Ibrahim Dawalbait Bakhat","raw_affiliation_strings":["Department of Radiotherapy, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiotherapy, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China","institution_ids":["https://openalex.org/I4210121771"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102897399","display_name":"Juan Ren","orcid":"https://orcid.org/0000-0002-8360-8286","observed_orcids":["https://orcid.org/0000-0002-8360-8286"]},"institutions":[{"id":"https://openalex.org/I4210121771","display_name":"First Affiliated Hospital of Xi'an Jiaotong University","ror":"https://ror.org/02tbvhh96","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210121771"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Juan Ren","raw_affiliation_strings":["Department of Radiotherapy, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiotherapy, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China","institution_ids":["https://openalex.org/I4210121771"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5102897399"],"corresponding_institution_ids":["https://openalex.org/I4210121771"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":4.7734,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.92827093,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":96},"biblio":{"volume":"17","issue":null,"first_page":"1873839","last_page":"1873839"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.007699999958276749,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11364","display_name":"Cholangiocarcinoma and Gallbladder Cancer Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.906000018119812},{"id":"https://openalex.org/keywords/antibiotic-exposure","display_name":"antibiotic exposure","score":0.8240000009536743},{"id":"https://openalex.org/keywords/corticosteroid-use","display_name":"corticosteroid use","score":0.9480000138282776},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.843999981880188},{"id":"https://openalex.org/keywords/cholangiocarcinoma","display_name":"cholangiocarcinoma","score":1.0},{"id":"https://openalex.org/keywords/hepatobiliary-malignancies","display_name":"hepatobiliary malignancies","score":0.9290000200271606},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.8949999809265137},{"id":"https://openalex.org/keywords/concomitant-medications","display_name":"concomitant medications","score":0.6909999847412109},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9490000009536743},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9860000014305115},{"id":"https://openalex.org/keywords/immunotherapy-toxicity-management","display_name":"immunotherapy toxicity management","score":0.38100001215934753},{"id":"https://openalex.org/keywords/antibiotic-stewardship","display_name":"antibiotic stewardship","score":0.6359999775886536},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.5989999771118164},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.5630000233650208},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.3970000147819519}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8984000086784363},{"id":"https://openalex.org/C2776804153","wikidata":"https://www.wikidata.org/wiki/Q210420","display_name":"Corticosteroid","level":2,"score":0.602400004863739},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.579800009727478},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5112000107765198},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.48410001397132874},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.47699999809265137},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4316999912261963},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.42239999771118164},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4162999987602234},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.4138999879360199},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.40049999952316284},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.3840000033378601},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.3693000078201294},{"id":"https://openalex.org/C2779399171","wikidata":"https://www.wikidata.org/wiki/Q1483951","display_name":"Malignancy","level":2,"score":0.35350000858306885},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3522999882698059},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.33629998564720154},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.325300008058548},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.31779998540878296},{"id":"https://openalex.org/C2779915747","wikidata":"https://www.wikidata.org/wiki/Q17058619","display_name":"Inverse probability weighting","level":3,"score":0.3084999918937683},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.29170000553131104},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2808000147342682},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2614000141620636},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.26030001044273376},{"id":"https://openalex.org/C41260117","wikidata":"https://www.wikidata.org/wiki/Q668064","display_name":"Hepatology","level":2,"score":0.2540999948978424}],"mesh":[{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000305","descriptor_name":"Adrenal Cortex Hormones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001650","descriptor_name":"Bile Duct Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001650","descriptor_name":"Bile Duct Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D001650","descriptor_name":"Bile Duct Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018281","descriptor_name":"Cholangiocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018281","descriptor_name":"Cholangiocarcinoma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D018281","descriptor_name":"Cholangiocarcinoma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D059016","descriptor_name":"Tumor Microenvironment","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.3389/fimmu.2026.1873839","doi":"https://doi.org/10.3389/fimmu.2026.1873839","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1873839","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1873839/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmid:42445194","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42445194","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13357655","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13357655/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:eb5fcc263cc34387a3ac1072df9c9529","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/eb5fcc263cc34387a3ac1072df9c9529","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2026.1873839","doi":"https://doi.org/10.3389/fimmu.2026.1873839","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1873839","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1873839/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[{"id":"https://openalex.org/G1102528","display_name":null,"funder_award_id":"81772793","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"},{"id":"https://openalex.org/G2914360155","display_name":null,"funder_award_id":"82473252","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"}],"funders":[{"id":"https://openalex.org/F4320321001","display_name":"National Natural Science Foundation of China","ror":"https://ror.org/01h0zpd94"},{"id":"https://openalex.org/F4320328010","display_name":"Yakult Bio-Science Foundation","ror":"https://ror.org/051635438"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7166556707.pdf","grobid_xml":"https://content.openalex.org/works/W7166556707.grobid-xml"},"referenced_works_count":43,"referenced_works":["https://openalex.org/W1982906652","https://openalex.org/W2019607817","https://openalex.org/W2036193982","https://openalex.org/W2119190881","https://openalex.org/W2138740885","https://openalex.org/W2144168223","https://openalex.org/W2765314233","https://openalex.org/W2782333299","https://openalex.org/W2784283849","https://openalex.org/W2795186863","https://openalex.org/W2805193208","https://openalex.org/W2888599070","https://openalex.org/W2915010259","https://openalex.org/W2972674410","https://openalex.org/W2982188023","https://openalex.org/W3000125713","https://openalex.org/W3039360174","https://openalex.org/W3090413519","https://openalex.org/W3091779617","https://openalex.org/W3127371144","https://openalex.org/W3158143977","https://openalex.org/W3165241302","https://openalex.org/W3174914912","https://openalex.org/W4200260883","https://openalex.org/W4281630496","https://openalex.org/W4281645619","https://openalex.org/W4292528167","https://openalex.org/W4308620781","https://openalex.org/W4310069342","https://openalex.org/W4318197608","https://openalex.org/W4319333797","https://openalex.org/W4382020994","https://openalex.org/W4386574963","https://openalex.org/W4388483819","https://openalex.org/W4389365553","https://openalex.org/W4399700968","https://openalex.org/W4401383838","https://openalex.org/W4407793214","https://openalex.org/W4409042267","https://openalex.org/W4410037246","https://openalex.org/W4415746551","https://openalex.org/W4416775572","https://openalex.org/W7125615191"],"related_works":["https://openalex.org/W3179282865","https://openalex.org/W4416775572","https://openalex.org/W4361268041","https://openalex.org/W3091779617","https://openalex.org/W4286296463","https://openalex.org/W3159878005","https://openalex.org/W3005383305","https://openalex.org/W3207597578","https://openalex.org/W4404764517","https://openalex.org/W3194509457"],"abstract_inverted_index":{"Background:":[0],"Concomitant":[1],"medications":[2],"may":[3,260],"influence":[4,261],"the":[5,11,29,132,262,284,296],"tumor-immune":[6],"microenvironment":[7],"and":[8,35,47,79,97,115,157,175,226,237,302],"potentially":[9],"affect":[10],"efficacy":[12],"of":[13,31,55,94,111,264,286,298,305],"immune":[14],"checkpoint":[15],"inhibitors":[16],"(ICIs),":[17],"yet":[18],"their":[19],"impact":[20],"in":[21,43,249,267],"hepatobiliary":[22,251],"malignancies":[23],"remains":[24],"poorly":[25],"defined.":[26],"We":[27],"evaluated":[28],"associations":[30],"antibiotic":[32,300],"(ATB)":[33],"exposure":[34,70,81,85,99,130,153,159,236,259],"indication-specific":[36],"corticosteroid":[37,207,238,273,288,306],"(CS)":[38],"use":[39,90,208,239,274,301],"with":[40,162,180,195,217,221,245,280],"clinical":[41,269],"outcomes":[42,248],"hepatocellular":[44],"carcinoma":[45],"(HCC)":[46],"cholangiocarcinoma":[48],"(CCA).":[49],"Methods:":[50],"In":[51,271],"this":[52],"retrospective":[53],"cohort":[54],"759":[56],"ICI-treated":[57,250],"patients":[58,63],"(511":[59],"HCC,":[60],"248":[61],"CCA),":[62],"were":[64,119,149,186,243],"stratified":[65],"into":[66],"four":[67],"groups:":[68],"no":[69,181],"(None,":[71],"n=251),":[72],"ATB":[73,84,156],"only":[74,77],"(n=135),":[75],"CS":[76,98,158],"(n=183),":[78],"combined":[80],"(Both,":[82],"n=190).":[83],"was":[86,160,215,277],"defined":[87],"as":[88,100],"systemic":[89],"within":[91],"\u00b130":[92],"days":[93,134],"ICI":[95,136,309],"initiation,":[96],"\u226510":[101],"mg":[102],"prednisone-equivalent":[103],"daily":[104],"for":[105,123,209,240,275],"\u22653":[106],"consecutive":[107],"days.":[108],"Inverse":[109],"probability":[110],"treatment":[112],"weighting":[113],"(IPTW)":[114],"multivariable":[116],"Cox":[117],"models":[118],"used":[120],"to":[121,131,138],"adjust":[122],"confounding.":[124],"Additional":[125],"baseline-only":[126,227],"sensitivity":[127,228],"analyses":[128,229],"restricted":[129],"30":[133],"before":[135],"initiation":[137],"reduce":[139],"potential":[140],"time-related":[141],"bias.":[142],"Results:":[143],"After":[144],"IPTW":[145],"adjustment,":[146],"baseline":[147],"covariates":[148],"well":[150],"balanced":[151],"across":[152,188],"groups.":[154],"Combined":[155],"associated":[161,216,244,279],"significantly":[163],"worse":[164],"overall":[165],"survival":[166,177,247],"(OS)":[167],"(adjusted":[168],"HR":[169],"3.09,":[170],"95%":[171],"CI":[172],"2.31-4.13;":[173],"p<0.001)":[174],"progression-free":[176],"(PFS)":[178],"compared":[179,220],"exposure.":[182],"Objective":[183],"response":[184,197],"rates":[185],"comparable":[187],"groups":[189],"(p=0.20),":[190],"suggesting":[191],"a":[192],"greater":[193],"association":[194],"impaired":[196],"durability":[198,263],"rather":[199],"than":[200],"initial":[201],"tumor":[202],"shrinkage.":[203],"Among":[204],"CS-treated":[205],"patients,":[206],"immune-related":[210],"adverse":[211],"event":[212],"(irAE)":[213],"management":[214],"improved":[218],"OS":[219],"non-irAE":[222,241],"indications":[223,242,307],"(p<0.01).":[224],"Landmark":[225],"demonstrated":[230],"generally":[231],"consistent":[232],"findings.":[233],"Conclusions:":[234],"Antibiotic":[235],"inferior":[246],"malignancies.":[252],"These":[253],"findings":[254,294],"suggest":[255],"that":[256],"concomitant":[257],"medication":[258],"immunotherapy":[265],"responses":[266],"real-world":[268],"settings.":[270],"contrast,":[272],"irAEs":[276],"not":[278],"compromised":[281],"outcomes,":[282],"supporting":[283],"importance":[285,297],"context-specific":[287],"administration":[289],"during":[290,308],"immunotherapy.":[291],"Clinically,":[292],"these":[293],"highlight":[295],"judicious":[299],"careful":[303],"consideration":[304],"treatment.":[310]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7166556707","counts_by_year":[{"year":2026,"cited_by_count":2}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2026-06-30T00:00:00"}
